Welcome to our dedicated page for Diversified Healthcare Tr SEC filings (Ticker: DHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Diversified Healthcare Trust (Nasdaq: DHC), a Maryland real estate investment trust that owns senior living, medical office and life science properties across the United States. Through these filings, investors can review detailed information on DHC’s financial condition, portfolio, capital structure and material events affecting the trust.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain audited and interim financial statements, segment discussions for the office and senior housing operating portfolios, risk factor disclosures and management’s analysis of results. These documents are central for understanding how DHC’s healthcare real estate assets, including senior living units and medical office and life science properties, contribute to revenue and operating performance.
Current reports on Form 8-K highlight specific events such as the announcement of quarterly financial results, investor presentations, the sale of management agreements for 116 senior living communities to seven different operators, and the issuance and partial redemption of senior secured notes. For example, recent 8-K filings describe DHC’s private offering of 7.250% senior secured notes due 2030, the related redemption of senior secured notes due 2026 and the posting of investor presentations that discuss these transactions.
DHC also has listed debt securities, including 5.625% Senior Notes due 2042 (trading as DHCNI) and 6.25% Senior Notes due 2046 (trading as DHCNL), which are referenced in its filings. Indentures and related agreements filed as exhibits outline covenants that limit additional indebtedness, require certain financial ratios and govern activities of subsidiary guarantors. Investors interested in DHC’s leverage, refinancing activities and covenant structure can analyze these documents for more detail.
On Stock Titan, SEC filings for DHC are updated as they become available from EDGAR. AI-powered tools summarize lengthy reports such as 10-Ks and 10-Qs, highlight key changes from prior periods and explain complex sections in simpler terms. Users can quickly identify items related to senior housing operations, medical office and life science properties, capital recycling, note offerings and redemptions, and other disclosures that shape the risk and return profile of Diversified Healthcare Trust.
Diversified Healthcare Trust filed a current report noting that it has made a new investor presentation available on its website. On October 8, 2025, the company posted this updated presentation, which is also attached to the report as Exhibit 99.1. The presentation is described as an investor communication and is furnished rather than filed, which typically means it is for informational purposes about the business rather than a formal change to financial statements or contracts.
DIVERSIFIED HEALTHCARE TRUST filed an 8-K reporting the execution of an indenture dated September 26, 2025 with U.S. Bank Trust Company, National Association as trustee. The indenture governs the company’s 7.250% Senior Secured Notes due 2030 and names certain subsidiaries as guarantors. The filing includes the form of the indenture and an Inline XBRL cover page.
The report is signed by Matthew C. Brown, Chief Financial Officer and Treasurer, indicating the company completed the documentation for the secured note issuance structure described in the filing.
Matthew C. Brown, the Chief Financial Officer and Treasurer of Diversified Healthcare Trust (ticker DHC), reported a sale of common shares on 09/16/2025. The Form 4 shows 9,711 shares were disposed of at a reported price of $4.37 per share, reducing his beneficial ownership to 113,954 shares. The filing states the disposition code is F(1), and the explanatory note says the transaction represents withholding of shares to satisfy tax withholding obligations upon vesting.
This filing is a routine insider tax-withholding sale rather than an open-market trade, and it was signed by Mr. Brown on 09/18/2025.
Christopher J. Bilotto, who serves as President and CEO and a director of Diversified Healthcare Trust (ticker shown in filing as NASDAQ:DHC), reported a transaction on 09/16/2025 disposing of 17,091 common shares at a price of $4.37 per share. The filing states the shares were withheld to pay a tax liability related to the vesting of previously issued securities. After the withholding, the report shows 245,899.89 common shares beneficially owned by Mr. Bilotto. The Form 4 is signed by the reporting person for this single-person filing.
Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ: DHC), reported a sale of 15,226 common shares on 09/16/2025 at a price of $4.37 per share. The filing lists 415,156.55 shares as his direct beneficial ownership following the transaction and indicates an indirect interest of 23,250,019 shares held by ABP Trust, for which Mr. Portnoy is sole trustee; he disclaims beneficial ownership except to the extent of his pecuniary interest. The filing explains the sale code as F, reflecting withholding of shares to satisfy a tax liability arising from vesting. The Form 4 was signed on 09/18/2025.
Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ:DHC), reported an equity award and resulting holdings. On 09/09/2025 Mr. Portnoy was awarded 81,775 common shares under the issuer's equity compensation plan, a transaction he reported on Form 4 with his signature dated 09/11/2025.
Following the award the filing shows 430,382.55 common shares listed as beneficially owned following the reported transaction and separately discloses 23,250,019 shares held by ABP Trust, of which Mr. Portnoy is sole trustee and which he may be deemed to beneficially own though he disclaims ownership except for his pecuniary interest.
Christopher J. Bilotto, President and CEO and a director of Diversified Healthcare Trust (NASDAQ: DHC), reported an equity award and additional share acquisitions. On 09/09/2025 Mr. Bilotto was awarded 81,775 common shares under the issuer's equity compensation plan. Following the award and prior reported activity, he beneficially owned 262,990.89 shares. The filing also notes 394.05 shares were acquired under a dividend reinvestment plan since his last Section 16 filing.
This Form 4 discloses a routine, compensation-related share award and reinvested dividends that increase an insider's stake; the report was signed on 09/11/2025.
Matthew C. Brown, CFO and Treasurer of Diversified Healthcare Trust (NASDAQ: DHC), received an award of 37,383 common shares under the issuer's equity compensation plan. After the award, his beneficial ownership in the company's common shares increased to 123,665 shares. The transaction is reported as an acquisition and reflects equity compensation rather than an open-market purchase or sale.
Diversified Healthcare Trust reported that it has posted a new investor presentation to its website, providing updated information for shareholders and other stakeholders.
The company also announced that AlerisLife Inc. has sold the management agreements for 116 senior living communities owned by Diversified Healthcare Trust to seven different operators, as part of AlerisLife’s sale of all its assets and wind-down of its business. These changes in community operators are described in a press release dated September 3, 2025, which is included as an exhibit.